Symbol="CYCC"
AssetType="Common Stock"
Name="Cyclacel Pharmaceuticals Inc"
Description="Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops drugs for the treatment of cancer and other proliferative diseases. The company is headquartered in Berkeley Heights, New Jersey."
CIK="1130166"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="8130400"
EBITDA="-28385000"
PERatio="None"
PEGRatio="0"
BookValue="0.809"
DividendPerShare="0"
DividendYield="0"
EPS="-1.91"
RevenuePerShareTTM="0.01"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.576"
ReturnOnEquityTTM="-1.051"
RevenueTTM="150000"
GrossProfitTTM="-455000"
DilutedEPSTTM="-1.91"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="13.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="74.57"
PriceToBookRatio="0.336"
EVToRevenue="6.1"
EVToEBITDA="0.58"
Beta="1.059"
num_52WeekHigh="2.41"
num_52WeekLow="0.5"
num_50DayMovingAverage="0.641"
num_200DayMovingAverage="0.794"
SharesOutstanding="12539200"
DividendDate="2020-04-15"
ExDividendDate="None"
symbol="CYCC"
open="0.67"
high="0.68"
low="0.63"
price="0.65"
volume="23520.00"
latest_trading_day="2023-07-28"
previous_close="0.65"
change="0.00"
change_percent="0.0773%"
aroon_positive_momentum_days="45"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="45"
Volume_recent_avg="64647"
Change_recent_avg="-0.01"
Delta_recent_avg="0.06"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-0.92"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="45"
Aroon_momentum_negative="55"
image_negative_thumbnail_id_1="138"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0038.jpeg"
image_negative_thumbnail_id_2="106"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0070.jpeg"
image_neutral_thumbnail_id_1="567"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0032.jpeg"
image_neutral_thumbnail_id_2="526"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0073.jpeg"
image_positive_thumbnail_id_1="1013"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0175.jpeg"
image_positive_thumbnail_id_2="973"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0135.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
